Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial.

Autor: Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G

Publikováno v: JAMA: Journal of the American Medical Association; 1/7/2009, Vol. 301 Issue 1, p63-73, 11p

The effect of ABO blood group on the diagnosis of von Willebrand disease

Autor: Gill, JC, Endres-Brooks, J, Bauer, PJ, Marks, WJ Jr, Montgomery, RR

Publikováno v: Blood; June 1987, Vol. 69 Issue: 6 p1691-1695, 5p

Measuring Physical Functioning Using Wearable Sensors in Parkinson Disease and Chronic Obstructive Pulmonary Disease (the Accuracy of Digital Assessment of Performance Trial Study): Protocol for a Prospective Observational Study.

Autor: de Graaf D; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, Netherlands., de Vries NM; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, Netherlands., van de Zande T; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, Netherlands., Schimmel JJP; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, Netherlands., Shin S; Verily Life Sciences, South San Fransisco, CA, United States., Kowahl N; Verily Life Sciences, South San Fransisco, CA, United States., Barman P; Verily Life Sciences, South San Fransisco, CA, United States., Kapur R; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, Netherlands.; Verily Life Sciences, South San Fransisco, CA, United States., Marks WJ Jr; Verily Life Sciences, South San Fransisco, CA, United States., van 't Hul A; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Respiratory Diseases, Nijmegen, Netherlands., Bloem B; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, Netherlands.

Publikováno v: JMIR research protocols [JMIR Res Protoc] 2024 May 07; Vol. 13, pp. e55452. Date of Electronic Publication: 2024 May 07.

Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson's disease in Japan.

Autor: Oyama G; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan. g_oyama@juntendo.ac.jp., Burq M; Verily Life Sciences, 269 East Grand Avenue, South San Francisco, CA, USA., Hatano T; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Marks WJ Jr; Verily Life Sciences, 269 East Grand Avenue, South San Francisco, CA, USA., Kapur R; Verily Life Sciences, 269 East Grand Avenue, South San Francisco, CA, USA., Fernandez J; Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-Ku, Tokyo, 103-0023, Japan., Fujikawa K; Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-Ku, Tokyo, 103-0023, Japan., Furusawa Y; Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-Ku, Tokyo, 103-0023, Japan., Nakatome K; Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-Ku, Tokyo, 103-0023, Japan., Rainaldi E; Verily Life Sciences, 269 East Grand Avenue, South San Francisco, CA, USA., Chen C; Verily Life Sciences, 269 East Grand Avenue, South San Francisco, CA, USA., Ho KC; Verily Life Sciences, 269 East Grand Avenue, South San Francisco, CA, USA., Ogawa T; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Kamo H; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Oji Y; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Takeshige-Amano H; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Taniguchi D; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Nakamura R; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Sasaki F; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Ueno S; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Shiina K; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Hattori A; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Nishikawa N; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Ishiguro M; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Saiki S; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan., Hayashi A; Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-Ku, Tokyo, 103-0023, Japan., Motohashi M; Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-Ku, Tokyo, 103-0023, Japan., Hattori N; Department of Neurology, Juntendo University Faculty of Medicine, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-8421, Japan.

Publikováno v: Scientific reports [Sci Rep] 2023 Mar 14; Vol. 13 (1), pp. 3600. Date of Electronic Publication: 2023 Mar 14.

Virtual exam for Parkinson's disease enables frequent and reliable remote measurements of motor function.

Autor: Burq M; Verily Life Sciences, South San Francisco, CA, USA. mburq@verily.com., Rainaldi E; Verily Life Sciences, South San Francisco, CA, USA., Ho KC; Verily Life Sciences, South San Francisco, CA, USA., Chen C; Verily Life Sciences, South San Francisco, CA, USA., Bloem BR; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, the Netherlands., Evers LJW; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, the Netherlands.; Radboud University, Institute for Computing and Information Sciences, Nijmegen, the Netherlands., Helmich RC; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, the Netherlands., Myers L; Verily Life Sciences, South San Francisco, CA, USA., Marks WJ Jr; Verily Life Sciences, South San Francisco, CA, USA., Kapur R; Verily Life Sciences, South San Francisco, CA, USA.

Publikováno v: NPJ digital medicine [NPJ Digit Med] 2022 May 23; Vol. 5 (1), pp. 65. Date of Electronic Publication: 2022 May 23.